BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maddali NK, Viswanath* IVK, Murthy* YLN, Bera R, Takhi M, Rao NS, Gudla V. Design, synthesis and molecular docking studies of quinazolin-4-ones linked to 1,2,3-triazol hybrids as Mycobacterium tuberculosis H37Rv inhibitors besides antimicrobial activity. Med Chem Res 2019;28:559-70. [DOI: 10.1007/s00044-019-02313-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Deng C, Yan H, Wang J, Liu K, Liu B, Shi Y. 1,2,3-Triazole-containing hybrids with potential antibacterial activity against ESKAPE pathogens. European Journal of Medicinal Chemistry 2022;244:114888. [DOI: 10.1016/j.ejmech.2022.114888] [Reference Citation Analysis]
2 Moura NM, Tomé AC. 1,2,3-Triazoles. Comprehensive Heterocyclic Chemistry IV 2022. [DOI: 10.1016/b978-0-12-818655-8.00067-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nehra N, Tittal RK, Ghule VD. 1,2,3-Triazoles of 8-Hydroxyquinoline and HBT: Synthesis and Studies (DNA Binding, Antimicrobial, Molecular Docking, ADME, and DFT). ACS Omega 2021;6:27089-100. [PMID: 34693129 DOI: 10.1021/acsomega.1c03668] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
4 Dutta A, Trivedi P, Gogoi D, Chetia P, Chaturvedi V, Sarma D. Anti-TB evaluation of novel 2,3-dihydroquinazolin-4(1H)-ones and in silico studies of the active compounds. Med Chem Res 2021;30:1366-76. [DOI: 10.1007/s00044-021-02733-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Tan Z, Deng J, Ye Q, Zhang Z. Triazole-containing hybrids with anti-Mycobacterium tuberculosis potential - Part I: 1,2,3-Triazole. Future Med Chem 2021;13:643-62. [PMID: 33619989 DOI: 10.4155/fmc-2020-0301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Depa N, Erothu H. Design, synthesis, antibacterial evaluation and molecular docking studies of novel pyrazole/1,2,4-oxadiazole conjugate ester derivatives. Med Chem Res 2021;30:1087-98. [DOI: 10.1007/s00044-021-02710-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Auti PS, George G, Paul AT. Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids. RSC Adv 2020;10:41353-92. [DOI: 10.1039/d0ra06642g] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 28.0] [Reference Citation Analysis]
8 Suresh A, Srinivasarao S, Khetmalis YM, Nizalapur S, Sankaranarayanan M, Gowri Chandra Sekhar KV. Inhibitors of pantothenate synthetase of Mycobacterium tuberculosis – a medicinal chemist perspective. RSC Adv 2020;10:37098-115. [DOI: 10.1039/d0ra07398a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]